Trials / Completed
CompletedNCT00772473
Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Clinvest · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To assess CGRP levels in saliva through the evolution of migraine.
Detailed description
The release of CGRP is assumed to be initiated early in the migraine process and increases as the headache intensifies. Levels of CGRP will be measured during the premonitory, mild, moderate, and severe phases of a single migraine attack and compared to the baseline value determined when the subject was headache free. Understanding of the clinical evolution of migraine CGRP release may have significant implications in acute treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | subjects personal triptan | Subjects will treat 1 migraine attack with their usual triptan |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2008-10-15
- Last updated
- 2009-05-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00772473. Inclusion in this directory is not an endorsement.